Publication Name	World Journal of Diabetes
Manuscript ID	78960
Country	Greece

Received	2022-07-24 15:04
Peer-Review Started	2022-07-24 15:07
To Make the First Decision
Return for Revision	2022-09-12 05:16
Revised	2022-09-16 18:44
Second Decision	2022-10-10 03:28
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-10-11 17:53
Articles in Press	2022-10-11 17:53
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-10-25 16:58
Typeset the Manuscript	2022-11-07 03:54
Publish the Manuscript Online	2022-11-11 10:05

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Effects of Chios mastic gum on cardiometabolic risk factors
Manuscript Source	Invited Manuscript
All Author List	Athanasia K Papazafiropoulou
ORCID	Author(s) ORCID Number Athanasia K Papazafiropoulou http://orcid.org/0000-0002-7596-4942
Funding Agency and Grant Number
Corresponding Author	Athanasia K Papazafiropoulou, MD, MSc, PhD, Attending Doctor, Research Scientist, The First Department of Internal Medicine and Diabetes Center, Tzaneio General Hospital of Piraeus, 1 Zanni and Afentouli Street, Piraeus 18536, Greece. pathan@ath.forthnet.gr
Key Words	Chios mastic gum; Glucose; Cardioprotection; Low-density lipoprotein-cholesterol; Triglycerides
Core Tip	Chios mastic gum (CMG), the resin produced by the trunk of Pistachia lentiscus var Chia, has been used for centuries as a strong phytotherapeutic therapy, primarily for the management of gastrointestinal diseases. Recently, there are studies demonstrating that it has hypolipidemic, cardioprotective and antidiabetic properties. Therefore, the aim of the present review is to summarize the existing literature data regarding the potential beneficial effects of CMG on cardiometabolic risk factors.
Publish Date	2022-11-11 10:05
Citation	Papazafiropoulou AK. Effects of Chios mastic gum on cardiometabolic risk factors. World J Diabetes 2022; 13(11): 921-925
URL	https://www.wjgnet.com/1948-9358/full/v13/i11/921.htm
DOI	https://dx.doi.org/10.4239/wjd.v13.i11.921

Full Article (PDF)	WJD-13-921.pdf
Full Article (Word)	WJD-13-921.docx
Manuscript File	78960_Auto_Edited-LM_Kerr C_Clear Copy.docx
Answering Reviewers	78960-Answering reviewers.pdf
Audio Core Tip	78960-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	78960-Conflict-of-interest statement.pdf
Copyright License Agreement	78960-Copyright license agreement.pdf
Peer-review Report	78960-Peer-review(s).pdf
Scientific Misconduct Check	78960-Bing-Wang JJ-2.png
Scientific Editor Work List	78960-Scientific editor work list.pdf
CrossCheck Report	78960-CrossCheck report.pdf